The global prostate cancer diagnostics market is forecasted to reach USD 7,112.2 Million by 2027, according to a new report by Reports and Data. The prostate cancer diagnostics market is observing demand attributed to the rising incidence of prostate cancer. It is the most common cause of death occurring as a result of cancer in American men. It has been found that nearly 1 out of 41 men die of prostate cancer. According to recent estimations, around 33,330 men will die of the disease in the year 2020.
Increasing awareness about cancer diagnosis at an early stage is a significant factor driving the market growth. A majority of prostate cancers or about 90.0% cases are detected when the disease is in the prostate gland and the nearby organs, and for such cases, the 5-year survival rate is about 100.0%, whereas the 5-year survival rate for the cases in which the disease has spread to other body parts is 31.0%.
The COVID-19 impact:
The COVID-19 pandemic has made it essential to repurpose the operating rooms for surgeries into intensive care units (ICUs) and pushed hospitals to accommodate patients beyond their full capacity of beds. As a result, in several cases, cancer patients' diagnostics and treatment were categorized as non-urgent. Further, the psychological influence of postponed diagnosis as a result of the COVID-19 pandemic cannot be undermined as when psychological, physical, and social health of patients are handled in a positive way, chances of patients’ survival have been seen to improve from a state of illness towards recovering from the disease. COVID-19 has had a significant and negative impact on cancer treatment and research, making a new health emergency for cancer patients’ management a necessity.
Top Companies Profiled in the Report Include:
Abbott Laboratories, Siemens Healthineers, F. Hoffman La Roche Ltd., Danaher Corporation, Agilent Technologies, Myriad Genetics Inc., Becton, Dickinson, and Company, Diasorin SPA, Genomic Health, and Beckman Coulter Inc., among others..
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3709
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3709
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
To know more about the report @ https://www.reportsanddata.com/press-release/global-prostate-cancer-diagnostics-market
Additionally, the report consists a detailed analysis of the segmentation of the Prostate Cancer Diagnostics market based on product types and end-use/application offered in the Prostate Cancer Diagnostics market.
Prostate Cancer Type Outlook (Revenue, USD Billion; 2017-2027)
Acinar Adenocarcinoma
Ductal Adenocarcinoma
Transitional Cell (or Urothelial) Cancer
Squamous Cell Cancer
Small Cell Prostate Cancer
Others
Test Type Outlook (Revenue, USD Billion; 2017-2027)
Preliminary Tests
Confirmatory Tests
PCA3
Transrectal Ultrasound
Biopsy
End-User Outlook (Revenue, USD Billion; 2017-2027)
Hospitals & Clinics
Diagnostic Centers
Research Institutes
Others
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Prostate Cancer Diagnostics market in these key regions.
Country-wise regional analysis covers:
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- France
- K.
- BENELUX
- Italy
- Spain
- Switzerland
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Turkey
- Rest of MEA
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
The global occlusion devices market size is expected to reach USD 4.62 Billion in 2028 and register a CAGR of 5.2% over the forecast period, according to the latest report by Reports and Data.
Also, occlusion devices are extensively used in various applications such as cardiology neurology, oncology and others.Rising demand for occlusion devices from hospitals, diagnostic centers & surgical centers, and ambulatory care centers will enhance market growth during the forecast period.
These devices are helpful in maintaining the proper function of a patient’s body after he/she has suffered from peripheral vascular diseases or other severe disorders.Rising number of surgeries associated with cardiological and neurological disorders has increased demand for occlusion devices, which, in turn, would help the market to grow at a fast pace.
Embolization helps to prevent blood flow to a tumor and minimizes blood loss at the time of surgeries.However, high cost of these devices may hamper growth of the occlusion devices market in the upcoming years.
Coupled with this, lack of advanced healthcare facilities in underdeveloped countries is anticipated to affect the occlusion devices market growth negatively in the near future.
Top Companies Profiled in the Report Include:Abbott LaboratoriesBraun Melsungen AGBoston Scientific CorporationCardinal HealthEdwards Lifesciences CorporationJohnson & JohnsonMedtronic PlcMerit Medical SystemsPenumbra, Inc.Stryker CorporationTerumo CorporationVascular ConceptsGet a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4642Market Overview: The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness.
The study segments the Spinal Implants and Surgery Devices industry in light of major classification such as product type, potential markets, application, and end-user.The report aims to offer a clear understanding of the market with respect to the manufacturers, suppliers, vendors, distributors, and key companies involved in the market.
The report has been formulated through extensive primary and secondary research along with verified and reliable data obtained from industry experts and professionals.
The key findings from the report have been sorted into charts, figures, tables, and other pictorial representations.Get a sample of the report @ https://www.emergenresearch.com/request-sample/393It further offers a comprehensive coverage of the strategic alliances such as mergers and acquisitions, joint ventures, collaborations, product launches, brand promotions, and partnerships, among others.
Key strategic alliances for product development and advancements is expected to add traction to market growth going ahead.
The report also covers an in-depth analysis of the key competitors of the market along with their growth strategies and business expansion plans.Top Companies Operating in the Spinal Implants and Surgery Devices Market and Profiled in the Report are:Stryker Corporation, RTI Surgical Inc., Nuvasive Inc., Zimmer Biomet Holdings Inc., Boston Scientific, Depuy Synthes, B. Braun Melsungen, Abbott Laboratories, Orthofix International NV, and Medtronic PLC, among others.The research report includes a separate chapter for qualitative analysis.
These factors have been carefully understood through secondary and primary sources.
H. Pylori (Helicobacter Pylori) Test Market Research Pune, India, October 2019/MRFR Press Release/- Market Research Future has published its Half-Cooked Research Report on the Global H. Pylori (Helicobacter Pylori) Test Market.The H. Pylori (Helicobacter Pylori) Test Market size analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.Global H. Pylori (Helicobacter Pylori) Test Market, by RegionNorth AmericaUSCanadaEuropeSpainGermanyItalyFranceUKRest of EuropeAsia-PacificAustraliaChinaJapanSouth KoreaIndiaRest of Asia-PacificMiddle East & AfricaUAESaudi ArabiaEgyptRest of Middle East and AfricaThe report also appraises the supervisory scenarios which affect various decisions in the market.
With all the data congregated and scrutinized using SWOT analysis, there is a vibrant picture of the competitive scenario of the Global H. Pylori (Helicobacter Pylori) Test Market.
Openings for the future market growth were uncovered and preoccupied competitive threats also textured.The H. Pylori (Helicobacter Pylori) Test Market growth sample report will provide valuable insight with an emphasis on the global market including some of the major players such As Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Quest Diagnostics Incorporated (US), F. Hoffmann-La Roche Ltd (Switzerland), Meridian Bioscience (US), CorisBioconcept SPRL (Belgium), Cardinal Health (US), Abbott Laboratories (US), QIAGEN (Germany), and Biohit Oyj (Finland).Reasons to Purchase this ReportQualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factorsProvision of market value (USD Billion) data for each segment and sub-segmentIndicates the region and segment that is expected to witness the fastest growth as well as to dominate the marketAnalysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each regionThe competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiledThe research analysts provide an elaborate description of the value chain and its distributor analysis.
This H. Pylori (Helicobacter Pylori) Test Market study provides comprehensive data which enhances the understanding, scope and application of this report.Access Complete Detailed TOC Research Report at https://www.marketresearchfuture.com/reports/helicobacter-pylori-test-market-8497Pylori (Helicobacter Pylori) Test Market Research Coverage:Changing market dynamics of the industryTo get a comprehensive overview of the H. Pylori (Helicobacter Pylori) Test Market.Historical, current and projected market size in terms of volume and valueIn-depth market segmentationCompetitive landscapeAbout Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.Contact:Market Research Future+1 646 845 9312Email: [email protected]
Global Blood Screening Market Forecast to 2027 encompasses crucial data about the global Blood Screening market and includes a thorough examination of technological development, market drivers, market share, market size, and regional segmentation.
The report also provides a comprehensive evaluation of the market trends, vital statistical data, accurate market estimations, and the key suppliers and manufacturers of the Blood Screening market.The report is also attuned with the currently ongoing COVID-19 pandemic and its effect on the key segments of the market.
The pandemic resulted in an economic slowdown and has directly affected the business sector by impacting the supply chains and availability of raw materials.
The report is updated with the impact of COVID-19 crisis, economic landscape, and present and future impact of COVID-19 on the market.
The report also aims to benefit the user by providing constructive data to gain insight into the market growth, size, and investment approaches.The key companies profiled in the market are: Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Ortho-Clinical Diagnostics, Inc., Grifols, Siemens Healthcare GmbH, SOFINA S.A, and Thermo Fisher Scientific.The report also covers a comprehensive analysis of the strategic alliances such as mergers and acquisitions, joint ventures, partnerships, collaborations, agreements, government and corporate deals, and product launches and brand promotions.
The report also offers a thorough analysis of the product portfolios, production capacity, gross margins, revenues, and costing of the key manufacturers and vendors.
Reports and Data has recently published a market research report on Global Hematology Diagnostics Market which is an extensive study of the industry and analyzes key factors affecting market growth such as government policies and regulatory framework, emerging technologies, current and future trends, market risks and challenges, opportunities, and growth prospects.
The report applies advanced tools such as SWOT analysis and Porter’s Five Forces analysis for an accurate estimation of the market.
The statistical data is explained by the means of graphs, charts, diagrams, figures, and tables to impart clear understanding of the market.
It provides critical insights into their market share, market size, revenue contribution, product portfolio, and manufacturing and production capacities.
The report also covers a list of mergers, acquisitions, joint ventures, product launches, collaborations, partnerships, brand promotions, and agreements, among others.
Moreover, it also discusses about the business expansion strategies and investment plans formulated by each key player.Key companies operating in the market and profiled in the report include: Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Sysmex Corporation, Beckman Coulter, Inc., Mindray Medical International Limited, HemoCue AB, Bio-Rad Laboratories Inc., Boule Diagnostics, Horiba Ltd., EKF Diagnostics, Drew Scientific Inc., Nihon Kohden Corporation, and Ortho Clinical Diagnostics.Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4057The report provides an in-depth assessment of the factors that are expected to generate lucrative opportunities for revenue generation and gain sizeable market share.
Global Geriatric Medicine Market is expected to reach USD 1.01 Trillion By 2024.
Geriatric medicine or geriatrics is a branch of medicine that focuses on medical issues and diseases of aging, and for old age.
There is no specific age at which patients may undergo geriatric physician.
The Geriatric Medicine Market is estimated to grow at a significant CAGR over the forecast period as the scope and its applications are rising enormously across the globe.Growing geriatric population, increasing occurrence of several target diseases, and developed and affordable healthcare and medicines sector are documented as major factors of Geriatric Medicine Market that are estimated to enhance the growth in the years to come.
However, difficulty in access to geriatric care among elderly patients in developing countries may restrain overall market growth in the coming years.
Geriatric Medicine Market is segmented based on therapeutic, medical condition, and region.Download Sample Report @ https://www.millioninsights.com/industry-reports/geriatric-medicine-market/request-sampleAntidepressants, analgesics, antipsychotics, antihypertensive, anticoagulant, statins, proton pump inhibitor, and antidiabetics are the therapeutics that could be explored in Geriatric Medicine in the forecast period.
